Serious liver disease in a patient receiving methotrexate and leflunomide.
Weinblatt
M E
ME
Brigham and Women's Hospital, Boston, MA, USA.
Dixon
J A
JA
Falchuk
K R
KR
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use* / Q000633:toxicity; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D004359:Drug Therapy, Combination; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use* / Q000633:toxicity; D007555:Isoxazoles / Q000627:therapeutic use* / Q000633:toxicity; D000077339:Leflunomide; D008099:Liver / Q000201:enzymology; D008103:Liver Cirrhosis / Q000139:chemically induced*; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use* / Q000633:toxicity; D008875:Middle Aged; D012720:Severity of Illness Index
D000894:Anti-Inflammatory Agents, Non-Steroidal; D007166:Immunosuppressive Agents; D007555:Isoxazoles; D000077339:Leflunomide; D008727:Methotrexate